Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OneVax

OneVax?uq=UG6efJS6
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$426K LATEST DEAL AMOUNT
2 INVESTORS
Description

Owner and operator of a drug development company. The company focuses on developing therapeutic devices designed to avert autoimmune diseases, with special emphasis on type 1 diabetes.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Therapeutic Devices
Primary Office
  • Florida Innovation Hub at UF
  • 747 Southwest 2nd Avenue Unit 312
  • Gainesville, FL 32601
  • United States

+1 (352) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OneVax’s full profile, request a free trial.

OneVax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2014 $426K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

OneVax Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
UF Innovate Accelerator/Incubator 000 0000 000000 0

OneVax Executive Team (4)

Name Title Board
Seat
Contact
Info
Mark Atkinson Ph.D Co-Founder & Acting Chief Executive Officer
Todd Brusko Ph.D Co-Founder & Chief Operations Officer
Clive Wasserfall Co-Founder & Chief Scientific Officer
Benjamin Keselowsky Ph.D Co-Founder